A Study to Evaluate Solrikitug in Participants With COPD (ZION)
ZION
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants With Chronic Obstructive Pulmonary Disease (ZION)
1 other identifier
interventional
171
5 countries
118
Brief Summary
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstructive Pulmonary Disease (COPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Aug 2024
118 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 11, 2024
CompletedStudy Start
First participant enrolled
August 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
March 23, 2026
March 1, 2026
1.9 years
July 3, 2024
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in blood eosinophil counts
To assess the effect of multiple doses of solrikitug on blood eosinophil counts compared with placebo
Through week 12
Secondary Outcomes (1)
Change from baseline in FEV1 Adverse events (AEs) and serious adverse events (SAEs)
Through week 12 To week 28
Study Arms (3)
Biological: Solrikitug High Dose
EXPERIMENTALSolrikitug
Placebo
OTHERPlacebo
Biological: Solrikitug Low Dose
EXPERIMENTALSolrikitug
Interventions
Solrikitug subcutaneous injection
Solrikitug subcutaneous injection
Eligibility Criteria
You may qualify if:
- At least 40 years of age and no older than 75 years.
- Documented diagnosis of COPD for at least 12 months prior to Screening, defined by the GOLD Guidelines (2023), and elevated blood eosinophils at screening.
- At Screening FEV1/FVC ratio must be \<0.70, and Post-bronchodilator FEV1 must be ≥40% to \<80% predicted normal value calculated using Global Lung Function Initiative (GLI) reference equations (Cooper et al 2017).
- Symptomatic (COPD Assessment Test \[CAT\] Score ≥10) at Screening Visit 1.
- Participants must be on 2 or more inhaled maintenance medications for management of their COPD, for at least 3 months prior to screening.
You may not qualify if:
- Female participant who is pregnant or breastfeeding.
- Participant has a known hypersensitivity to any component of the formulation of solrikitug, including any of the excipients, or a history of anaphylactic reaction to any therapeutic monoclonal antibody.
- Participant has history or evidence of any clinically significant cardiovascular, hematologic, hepatic, immunologic, metabolic, urologic, neurologic, dermatologic, psychiatric, renal and/or other major disease or malignancy, or any other condition that in the opinion of the Investigator or Medical Monitor might obfuscate the study data.
- Any other pulmonary disease than COPD that in the opinion of the Investigator, the severity of the disorder would impact the conduct of the study.
- Undergone major lung surgery, within 1 year of Screening Visit 1.
- Participant has a lower respiratory tract infection that required antibiotics within 6 weeks prior to Screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uniquity One (UNI)lead
- DevPro Biopharmacollaborator
Study Sites (118)
University of Alabama at Birmingham Hospital
Birmingham, Alabama, 35294, United States
Syed Research Consultants
Sheffield, Alabama, 35660, United States
Phoenix Medical Group
Peoria, Arizona, 85381, United States
Epic Medical Research-Surprise
Sun City, Arizona, 85351, United States
Alliance for Multispecialty Research
Tempe, Arizona, 85281, United States
Novak Clinical Research
Tucson, Arizona, 85741, United States
Antelope Valley Clinical Trials
Lancaster, California, 93534, United States
Ark Clinical Research - Ballinger
Long Beach, California, 90815, United States
Downtown LA Research Center, Inc.
Los Angeles, California, 90017, United States
Newport Native MD, Inc.
Newport Beach, California, 92663, United States
OM Research
Oxnard, California, 93036, United States
Prospective Research Innovations, Inc.
Rancho Cucamonga, California, 91730, United States
Velocity Clinical Research - Denver
Englewood, Colorado, 80110, United States
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Access Research Institute
Brooksville, Florida, 34613, United States
Innovative Research of West Florida, Inc.
Clearwater, Florida, 33756, United States
Clinical Research of West Florida - Clearwater
Clearwater, Florida, 33765, United States
JY Research Institute
Cutler Bay, Florida, 33189, United States
Hillcrest Medical Research, LLC
DeLand, Florida, 32720, United States
North Florida Foundation for Research and Education
Gainesville, Florida, 32608, United States
Direct Helper Research Center
Hialeah, Florida, 33012, United States
Homestead Associates in Research Inc.
Homestead, Florida, 33033, United States
AppleMed Research Group, LLC
Miami, Florida, 33126, United States
Y&L Advanced Health Care, Inc.
Miami, Florida, 33144, United States
Reliant Medical Research LLC
Miami, Florida, 33165, United States
Valencia Medical & Research Center
Miami, Florida, 33174, United States
De La Cruz Research Center, LLC
Miami, Florida, 33184, United States
Coral Research Clinic Corporation
Miami, Florida, 33186, United States
Pro-Care Research Center, Corp.
Miami Gardens, Florida, 33014, United States
San Marcus Research Clinic, Inc.
Miami Lakes, Florida, 33014, United States
Florida Institute for Clinical Research
Orlando, Florida, 32825, United States
Sarasota Clinical Research
Sarasota, Florida, 34239, United States
TBC Research
Tamarac, Florida, 33321, United States
Clinical Research of West Florida - Tampa
Tampa, Florida, 33606, United States
Appalachian Clinical Research, LLC
Adairsville, Georgia, 30103, United States
Pulmonology, Sleep, Asthma, and Allergy Center - Dublin
Dublin, Georgia, 31021, United States
CPCC - Research, LLC
East Point, Georgia, 30344, United States
Centricity Research
Rincon, Georgia, 31326, United States
Velocity Clinical Research - Boise
Meridian, Idaho, 83642, United States
OSF HealthCare Saint Francis Medical Center
Peoria, Illinois, 61606, United States
Indiana Medical Research Institute
Merrillville, Indiana, 46410, United States
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
The Research Group of Lexington, LLC
Lexington, Kentucky, 40503, United States
Tandem Clinical Research
Metairie, Louisiana, 70006, United States
Care Access - Shreveport
Shreveport, Louisiana, 71105, United States
Mayflower Clinical
South Dartmouth, Massachusetts, 02747, United States
Revival Research Institute, LLC
Dearborn, Michigan, 48126, United States
Henry Ford Health System
Detroit, Michigan, 48207, United States
Pulmonary Research Institute of SE Michigan
Farmington Hills, Michigan, 48336, United States
Revive Research Institute
Southfield, Michigan, 48075, United States
Midwest Chest Consultants
Saint Charles, Missouri, 63301, United States
Montana Medical Research, Inc.
Missoula, Montana, 59808, United States
Henderson Trials
Henderson, Nevada, 89052, United States
Rutgers, The State University of New Jersy
New Brunswick, New Jersey, 08901, United States
Certified Research Associates Finger Lakes Medical Research, LLC
Cortland, New York, 13045, United States
Corning Center for Clinical Research Smith Allergy & Asthma Specialists
Horseheads, New York, 14845, United States
Northwell Health
New Hyde Park, New York, 11042, United States
OnSite Clinical Solutions
Charlotte, North Carolina, 28277, United States
Clinical Research of Gastonia
Gastonia, North Carolina, 28054, United States
Triad Clinical Trials
Greensboro, North Carolina, 27410, United States
Peters Medical Research
High Point, North Carolina, 27260, United States
Advanced Respiratory and Sleep Medicine
Huntersville, North Carolina, 28078, United States
Accellacare Wilmington
Wilmington, North Carolina, 28401, United States
Southeastern Research Center
Winston-Salem, North Carolina, 27103, United States
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
Remington Davis
Columbus, Ohio, 43215, United States
NexGen Research
Lima, Ohio, 45801, United States
OK Clinical Research
Edmond, Oklahoma, 73034, United States
Velocity Clinical Research - Grants Pass
Grants Pass, Oregon, 97257, United States
Velocity Clinical Research - Medford
Medford, Oregon, 97504, United States
Clinical Research Associates of Central PA
DuBois, Pennsylvania, 15801, United States
Temple University
Philadelphia, Pennsylvania, 19140, United States
University of Pittsburgh/UPMC
Pittsburgh, Pennsylvania, 15213, United States
Allergy and Clinical Immunology Associates
Pittsburgh, Pennsylvania, 15241, United States
AnMed Health
Anderson, South Carolina, 29621, United States
Velocity Clinical Research - Anderson
Anderson, South Carolina, 29621, United States
Medical University of South Carolina
Charleston, South Carolina, 29245, United States
Velocity Clinical Research - Columbia
Columbia, South Carolina, 29204, United States
Velocity Clinical Research - Gaffney
Gaffney, South Carolina, 29340, United States
Velocity Clinical Research - Greenville
Greenville, South Carolina, 29615, United States
Clinical Research of Rock Hill
Rock Hill, South Carolina, 29732, United States
Velocity Clinical Research - Spartanburg
Spartanburg, South Carolina, 29303, United States
Velocity Clinical Research - Union
Union, South Carolina, 29379, United States
Pulmonary & Sleep Specialists
Dickson, Tennessee, 37055, United States
Premier Research Center, LLC
Hendersonville, Tennessee, 37075, United States
New Phase Research & Development
Knoxville, Tennessee, 37909, United States
TTS Research
Boerne, Texas, 78006, United States
Proactive RGV
Brownsville, Texas, 78520, United States
Ten20 Clinical Research, LLC
Carrollton, Texas, 75010, United States
IntraCare Health Center
Dallas, Texas, 75254, United States
IntraCare Clinical
Greenville, Texas, 75401, United States
Axsendo Clinical Research
Houston, Texas, 77030, United States
Gulf Coast Clinical Research
Houston, Texas, 77070, United States
R & H Clinical Research
Katy, Texas, 77494, United States
IntraCare Health Center
McKinney, Texas, 75071, United States
SMS Clinical Research
Mesquite, Texas, 75149, United States
ADP Clinical Research
Splendora, Texas, 77372, United States
Alpine Research Organization, Inc.
Layton, Utah, 84041, United States
Velocity Clinical Research - Hampton
Hampton, Virginia, 23666, United States
Core Clinical
Everett, Washington, 98201, United States
Confluence Health
Wenatchee, Washington, 98801, United States
Momentum Taringa
Taringa, Brisbane, QLD 4068, Australia
Northside Health
Coffs Harbour, New South Wales, 2450, Australia
Momentum St. Leonards
Sydney, New South Wales, 2065, Australia
Momentum Wellers Hill
Tarragindi, Queensland, 4121, Australia
Dr. Syed Anees Medicine Professional Corporation
Windsor, Ontario, N8X 5A6, Canada
Pacific Clinical Research Network Auckland - PCRN West Auckland
New Lynn, Auckland, 0600, New Zealand
Momentum Wellington
Mount Cook, Wellington Region, 6021, New Zealand
Pacific Clinical Research Network Auckland - PCRN Auckland
Auckland, 1024, New Zealand
New Zealand Respiratory & Sleep Institute (NZRSI)
Auckland, 1051, New Zealand
Momentum Hawke's Bay
Hastings, 4122, New Zealand
Momentum Tauranga
Tauranga, 3110, New Zealand
Momentum Kapiti
Waikanae, 5036, New Zealand
The Medicines Evaluation Unit, an IQVIA business
Wythenshawe, Manchester, M23 9QZGB, United Kingdom
Bradford Teaching Hospitals NHS Foundation Trust
Bradford, BD9 6RJ, United Kingdom
Velocity Clinical Research High Wycombe
High Wycombe, HP11 2QW, United Kingdom
Velocity Clinical Research - Bristol
London, N12 8BU, United Kingdom
Queen Anne Street Medical Centre
London, W1T 6AH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andrew W Lee, MD
Vice President, Clinical Research
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2024
First Posted
July 11, 2024
Study Start
August 14, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03